Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Wilson Wolf
AddedFeb 13, 2024
UpdatedJun 18, 2026
Wilson Wolf

Wilson Wolf

Late Stage Private

Minnesota-based Wilson Wolf, pioneering innovative mammalian cell culture devices since 1998.

HQ
Saint Paul, MN, US
Founded
1998
Overview
Compare
Fundraising
Employees
Website

Founded in 1998 and based in St. Paul, Minnesota, Wilson Wolf is dedicated to pioneering the development of innovative mammalian cell culture devices. The company's core mission is to advance cell culture technology to facilitate groundbreaking research and therapeutic applications. Wilson Wolf's products are designed to improve the efficiency and effectiveness of cell culture processes, serving researchers and biotechnologists in various scientific fields.

Wilson Wolf has made significant strides in the biotechnology industry, earning recognition for its cutting-edge cell culture solutions. The company has attracted notable investors and collaborators, contributing to its growth and impact on scientific research. Through its innovative products, Wilson Wolf has enhanced the capabilities of laboratories worldwide, supporting advancements in medical research and therapeutic development.

Wilson Wolf - Similar Companies

Flexcell logo

Flexcell

flexcellint.com

Cell Microsystems logo

Cell Microsystems

SciKon Innovation logo

SciKon Innovation

PurCell Bio logo

PurCell Bio

purcell-bio.com

Cellara logo

Cellara

Reprise Biomedical logo

Reprise Biomedical

reprisebio.com

Ronawk logo

Ronawk

ronawk.com

Lucid Scientific logo

Lucid Scientific

lucidsci.com

Wexis logo

Wexis

wexisgp.com

Cellworks logo

Cellworks

Spheringenics logo

Spheringenics

Wound Care Technologies logo

Wound Care Technologies

Minnesota Medical Technologies logo

Minnesota Medical Technologies

mnmedtech.us

Flaskworks logo

Flaskworks

Connect Wolf logo

Connect Wolf

connectwolf.com

Wilson Wolf - Quick Facts

Who are Wilson Wolf's competitors?

Companies similar to Wilson Wolf include Flexcell, Cell Microsystems, SciKon Innovation and PurCell Bio.

When was Wilson Wolf founded?

Wilson Wolf was founded in 1998.

Where is Wilson Wolf's headquarters located?

Wilson Wolf's headquarters is located in Saint Paul, MN, US.

When was Wilson Wolf's last funding round?

Wilson Wolf's most recent funding round was for $257M (USD) in March 2023.

How much has Wilson Wolf raised to-date?

As of Mar 1, 2023, Wilson Wolf has raised a total of $257M (USD).

How many employees does Wilson Wolf have?

Wilson Wolf has 30 employees as of Feb 4, 2024.

Wilson Wolf - Classification

Ownership
  • Private
Technology
  • Biotech
Revenue
  • Recurring
  • Transactional
Main Product
  • Cell Culture Devices
Tags
  • Hardware
  • Software
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software